학술논문
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Document Type
Article
Author
Huffman, B.M.; Singh, H.; Metayer, K.A.; Murray, S.; Bird, A.; Abrams, T.A.; Biller, L.H.; Chan, J.A.; Meyerhardt, J.A.; Mccleary, N.J.; Patel, A.K.; Wisch, J.S.; Yurgelun, M.B.; Van Allen, E.M.; Mayer, R.J.; Schlechter, B.; Ng, K.; Hanna, G.J.; Rubinson, D.A.; Cleary, J.M.; Ali, L.R.; Horick, N.; Goessling, W.; Parikh, A.; Wang, S.J.; Hoffman, M.T.; Dougan, S.K.; Mouw, K.; Zerillo, J.A.; Reardon, B.; Welsh, E.L.; Pfaff, K.; Clark, J.W.; Kumar, S.; Del Vecchio Fitz, C.; Kuperwasser, C.; Coveler, A.L.; Rodig, S.
Source
In: Journal for ImmunoTherapy of Cancer . (Journal for ImmunoTherapy of Cancer, 25 January 2024, 12(1))
Subject
Language
English
ISSN
20511426